2016
DOI: 10.1016/j.arteri.2015.09.002
|View full text |Cite
|
Sign up to set email alerts
|

Consenso sobre los objetivos y pautas de actuación en el control del colesterol ligado a lipoproteínas de baja densidad en pacientes de muy alto riesgo cardiovascular

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 35 publications
0
1
0
1
Order By: Relevance
“…In Phase 1, a literature review was performed. 26,[28][29][30][31][32] During Phase 2, the Delphi questionnaire was developed based on the review of the literature and the scientific committee's experience. In phases 3 and 4, the Delphi questionnaire was answered by a panel of experts, results were analyzed, and the manuscript was prepared.…”
Section: Methodsmentioning
confidence: 99%
“…In Phase 1, a literature review was performed. 26,[28][29][30][31][32] During Phase 2, the Delphi questionnaire was developed based on the review of the literature and the scientific committee's experience. In phases 3 and 4, the Delphi questionnaire was answered by a panel of experts, results were analyzed, and the manuscript was prepared.…”
Section: Methodsmentioning
confidence: 99%
“…El tratamiento en los pacientes con muy alto RCV comenzará con la elección de las estatinas más potentes a las dosis máximas toleradas (atorvastatina, rosuvastatina) 95 . En los pacientes con cardiopatía isquémica con alto riesgo de desarrollar diabetes tipo 2 (prediabetes), como son los pacientes con sobrepeso, obesidad, síndrome metabólico o en los que ya padecen diabetes tipo 2, la pitavastatina a dosis máxima estaría especialmente indicada por su efecto neutro en el riesgo de diabetes de nueva aparición 96 .…”
Section: 8 Tratamiento En Pacientes De Muy Alto Riesgo Cardiovascularunclassified